Co-inhibition of SMAD and MAPK signaling enhances 124I uptake in BRAF-mutant thyroid cancers is a research paper published in Endocrine Related Cancer (2021). On theSindex it has a DataRank of 0. It has been cited 18 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA050706
NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: R01 CA249663
NCI NIH HHS
Grant: R01 CA072597
NCI NIH HHS
Grant: P50 CA172012
NCI NIH HHS
Grant: T32 CA160001
NCI NIH HHS
Grant: R01 CA173592
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
National Institutes of Health
Grant: 5R01CA249663-05
Improving efficacy of radioiodine treatment of thyroid cancer
National Institutes of Health
Grant: 5T32CA160001-03
Translational Research in Oncology Training Program
National Institutes of Health
Grant: 5R01CA050706-31
Molecular Pathophysiology of Thyroid Cell Growth
National Institutes of Health
Grant: 5P50CA172012-02
Biospeciment Repository Core
FWCI
1.11
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals